Abstract:Atherosclerotic renal artery stenosis may cause hypertension, chronic kidney disease and heart failure, but large randomized control trials to date have shown no major additional benefit of renal revascularization over optimal medical management. However, these trials did not consider outcomes specifically in relation to clinical presentations. Given that atherosclerotic renal artery stenosis is a heterogenous condition, measures of success likely differ according to the clinical presentation. Our retrospective study objectives were to determine the effects of revascularization when applied to specific clinical presentations and after careful multi-disciplinary team review.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is: **To improve the clinical outcomes of patients with atherosclerotic renovascular disease (ARVD), especially by reviewing through a multidisciplinary team (MDT) and selecting patients suitable for revascularization according to specific clinical manifestations**. ### Specific problem description: 1. **Background and objectives**: - Atherosclerotic renal artery stenosis (ARAS) may lead to hypertension, chronic kidney disease, and heart failure. - Previous large - scale randomized controlled trials (RCTs) have shown that on the basis of optimized medical treatment, renal revascularization has no significantly additional benefits. However, these trials did not specifically consider the impact of different clinical manifestations on outcomes. - ARAS is a heterogeneous disease, and the criteria for success may vary according to clinical manifestations. 2. **Research purposes**: - Through a retrospective study, evaluate the effect of revascularization under specific clinical manifestations and after careful review by a multidisciplinary team. - Determine the impact of revascularization on specific clinical manifestations (such as refractory hypertension, worsening renal function, heart failure syndrome, etc.). ### Method overview: - **Research design**: Retrospective cohort study. - **Research subjects**: All patients with at least one - side renal artery stenosis > 50% detected by imaging examinations from January 2015 to January 2020. - **Multidisciplinary team review**: According to international guidelines, the multidisciplinary team discusses and decides whether to perform revascularization. - **Main outcome measures**: - For patients with renovascular hypertension: Blood pressure control and the number of antihypertensive drugs. - For patients with ischemic nephropathy: Changes in estimated glomerular filtration rate (eGFR). - For patients with heart failure syndrome: Heart failure readmission rate. ### Conclusions: - Multidisciplinary team discussions successfully identified a group of patients more likely to benefit from revascularization, based on three key factors: clinical manifestations, the severity of renal artery lesions, and the state of the kidney distal to the renal artery stenosis. - Through this selection method, most patients can achieve better clinical outcomes after revascularization, especially for their specific clinical manifestations. ### Formula representation: - Blood pressure control: \[ \text{BP} = 160/77 \, \text{mmHg} \] (pre - operation) vs \[ \text{BP} = 137/74 \, \text{mmHg} \] (post - operation) - eGFR change: \[ \Delta \text{eGFR} = - 5 \, \text{ml/min/1.73m}^2/\text{year} \] (pre - operation) vs \[ \Delta \text{eGFR} = - 1.3 \, \text{ml/min/1.73m}^2/\text{year} \] (post - operation) Through this method, the study aims to improve the clinical outcomes of patients with atherosclerotic renovascular disease, especially in the case of making individualized treatment decisions under the guidance of a multidisciplinary team.

Improving outcomes in atherosclerotic renovascular disease: importance of clinical presentation and multi-disciplinary review

Endovascular Versus Medical Management of Atherosclerotic Renovascular Disease: Update and Emerging Concepts

Research Progress of Atherosclerotic Renal Artery Stenosis and Cardiovascular Disease

Atherosclerotic Renovascular Disease: A KDIGO (Kidney Disease: Improving Global Outcomes) Controversies Conference

When and How Should We Revascularize Patients With Atherosclerotic Renal Artery Stenosis?

Long Term Outcomes After Renal Revascularization for Atherosclerotic Renovascular Disease in the ASTRAL Trial

A review of the current treatment of renal artery stenosis

Quality of Life Effects of Renal Artery Stenting Versus Medical Therapy for Atherosclerotic Renal-Artery Stenosis: Results from the Randomized CORAL Trial

When Revascularization May Be Appropriate in Atherosclerotic Renal Artery Stenosis

Results of surgical treatment for atherosclerotic renovascular occlusive disease

Successful Endovascular Treatment of Chronic Renal Artery Occlusion: a Preliminary Retrospective Case Series Including 15 Patients

Stent angioplasty of severe atherosclerotic ostial renal artery stenosis in patients with diabetes mellitus and nephrosclerosis

Atherosclerotic renal artery stenosis--diagnosis and treatment

Myocardial revascularisation in renal dysfunction: a systematic review and meta-analysis

Treatment progress of ischemic renal disease

Atherosclerotic Renal Artery Stenosis and Hypertension: Pragmatism, Pitfalls, and Perspectives

Renal artery stenosis: medical versus interventional therapy

Clinical Efficacy Analysis of Intervention Treatment for Patients with Atherosclerotic Renal Artery Stenosis

Interventions for renal artery stenosis: Appraisal of novel physiological insights and procedural techniques to improve clinical outcome

Review of Renal Artery Stenosis and Hypertension: Diagnosis, Management, and Recent Randomized Control Trials